Is once-daily delayed release metformin better than the other forms of metformin?

We have studies that show exercise for older women is very beneficial; new study shows benefits for the young.

Does insulin cause more deaths and cardiovascular outcomes than GLP-1 agonist receptors?

In part 3 of this exclusive interview, Dr. Eckel discusses the new PCSK9 Inhibitors and their LDL-lowering effects, and why they are beneficial for statin-intolerant patients.

In part 2 of this exclusive interview, Dr. Eckel discusses the new diabetes drugs that offer treatment benefits beyond glucose control, and why 1 + 1 + 1 + 1 may add up to more than 4 when impacting multiple risks.

In Part 1 of this exclusive interview, Dr. Eckel discusses the new PCSK9 inhibitors, treating complicated patients, and the challenges of type 2.

Recently Beta Bionics, the makers of the iLet artificial pancreas, reached a significant milestone: raising $1 million through online public fundraising. It is no longer a question of if an artificial pancreas will exist, but of when it will become commercially available. With every major insulin pump company working in this area, along with many startups, patients will not just have one system, but several they can chose from.

Since the result of this Presidential election will have a major impact on our nation’s healthcare, which candidate are you leaning towards? Follow the link to share your opinion!

Less-stringent A1C goals (7.5 - 8.0%) may be acceptable in certain individuals with type 2 diabetes. Which factor(s) support less stringent goals? A) Limited life expectancy B) History of severe hypoglycemia C) Multiple comorbidities D) All of the above Did you get it right? Follow the link to find out!

BlueLoop is a tool for children with diabetes. It provides care coordination among caregivers, improving a child’s and family’s ability to manage diabetes, especially when the child is away from home.